Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

11drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: BAY2965501 ×

BAY2965501

This drug is selected. Its supporting articles are shown below.

BAY29655012

Articles mentioning BAY2965501

2 articles · page 1 of 1

588 Selective inhibition of Diacylglycerol kinase zeta exhibits increased T cell activation and anti-tumor immunity, demonstrating pharmacodynamic proof of mechanism in the FIH trial of BAY2965501

jitc · abstract · 2025-11-04 · 6 matching annotations

97.6%

BAY2965501 pembrolizumab BAY2965501-induced NCT05614102 solid tumors IRBs

…inhibition dependent changes in anti-tumor immunity.Conclusions BAY2965501 demonstrates pharmacodynamic PoM in monotherapy and combination…

614 Treatment with diacylglycerol kinase (DGK) alpha specific inhibitor BAY2862789 exhibits combination potential with DGK zeta inhibition in biomarker assays during FIH monotherapy trial

jitc · abstract · 2025-11-04 · 5 matching annotations

98.0%

BAY2965501 BAY2862789 NCT05858164 cancer

…rmed on a subset of patients (n=>10), including the addition of BAY2965501, demonstrated synergistic elevation in IFNγ and IL2 production …